RAC 0.63% $1.59 race oncology ltd

General Comments / Chat, page-2777

  1. 8,616 Posts.
    lightbulb Created with Sketch. 1423
    Yes, that would be a hybrid of a full buyout and a partnership. It could happen. And the spin-off royalty company could eventually be sold also.

    BTW, my concept of a "partnership" is that the partner designs and pays for the P3, approval and commercialisation. I don't see any scenario where RAC would perform those tasks.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.